Ferrofluid for radiofrequency capacitive hyperthermia: In-vitro study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F70883521%3A28610%2F17%3A63516982" target="_blank" >RIV/70883521:28610/17:63516982 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Ferrofluid for radiofrequency capacitive hyperthermia: In-vitro study

Popis výsledku v původním jazyce

The current work deals with preparation and characterization of electrically lossy ferrofluid which can be used as a mediator for radio frequency (RF) - capacitive hyperthermia method. To this end, ferrofluid that can absorb the energy of alternating electrical field at the frequencies commonly employed in RF-capacitive hyperthermia (13.56 and 27.12 MHz) has been prepared by co-precipitation method. This ferrofluid comprises of electrically conductive component with core-shell structure, i.e. magnetite nanoparticles (NPs) coated by dextran, organized in chain-like structure. The effect of RF - capacitive hyperthermia in the presence of mediator was studied on the series of tests performed on HaCaT and HepG2 cell lines using MMT test. The RF-electrical field (13.56 MHz) with controllable power output was applied using the EHY-110 SA (Oncotherm group) to increase the temperature of samples from 37°C up to target temperature of 44°C. The results of in-vitro test clearly indicate that the usage of capacitive heating of obtained ferrofluid substantially contribute to cytotoxic effect of hyperthermia treatment.

Název v anglickém jazyce

Ferrofluid for radiofrequency capacitive hyperthermia: In-vitro study

Popis výsledku anglicky

The current work deals with preparation and characterization of electrically lossy ferrofluid which can be used as a mediator for radio frequency (RF) - capacitive hyperthermia method. To this end, ferrofluid that can absorb the energy of alternating electrical field at the frequencies commonly employed in RF-capacitive hyperthermia (13.56 and 27.12 MHz) has been prepared by co-precipitation method. This ferrofluid comprises of electrically conductive component with core-shell structure, i.e. magnetite nanoparticles (NPs) coated by dextran, organized in chain-like structure. The effect of RF - capacitive hyperthermia in the presence of mediator was studied on the series of tests performed on HaCaT and HepG2 cell lines using MMT test. The RF-electrical field (13.56 MHz) with controllable power output was applied using the EHY-110 SA (Oncotherm group) to increase the temperature of samples from 37°C up to target temperature of 44°C. The results of in-vitro test clearly indicate that the usage of capacitive heating of obtained ferrofluid substantially contribute to cytotoxic effect of hyperthermia treatment.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials

Projekt

<a href="/cs/project/LO1504" target="_blank" >LO1504: Centrum polymerních systémů plus</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

8th International Conference on Nanomaterials - Research &amp; Application (NANOCON 2016)

ISBN

978-80-87294-71-0

ISSN

—

e-ISSN

neuvedeno

Počet stran výsledku

6

Strana od-do

449-454

Název nakladatele

Tanger Ltd.

Místo vydání

Ostrava

Místo konání akce

Brno

Datum konání akce

19. 10. 2016

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

000410656100079